First name,Last name,Preferred title,Overview,Position,Department,Individual
Andy,Thomas,Assistant Professor,"Our primary research objective is to develop new methods by investigating and harnessing the reactivity of highly unstable intermediates. Essential to improving mechanistic understanding is the development of new strategies that allow us to monitor fleeting intermediates and manipulate their reactivity. To supplement our mechanism driven methodology development, we will develop a new rapid multiple injection NMR (RMI-NMR) system to monitor and control the reactivity of transient species. Representative areas of research interest include the development of new organic transformations; and the development of catalyst-transfer polymerization reactions.",Assistant Professor,Chemistry,https://scholars.library.tamu.edu/vivo/display/n07836ca1
Jonathan,Sczepanski,Assistant Professor,"Our primary research goals are to develop and apply novel tools for studying DNA damage in the context of chromatin and to explore new avenues for RNA-based therapeutics and diagnostics. By combining expertise in chemical biology, molecular biology, and molecular evolution, our lab addresses challenges associated with studying and targeting noncoding RNAs from a unique perspective. In addition, we utilize modern chemical biology techniques to develop designer chromatin systems for studying DNA damage. We are seeking motivated individuals who wish to gain experience in chemical biology, molecular biology, and in vitro evolution techniques.",Assistant Professor,Chemistry,https://scholars.library.tamu.edu/vivo/display/ncc157d6e
Shiqing,Xu,Assistant Professor,"Our research aims to develop innovative synthetic methodologies and therapeutic approaches, and apply them to solving pressing problems of biological and medical importance. New synthetic methodologies and strategies (e.g. non-traditional disconnections and C-H functionalization) have great impacts on the discovery of transformational medicines by enabling the rapid and efficient synthesis of novel, diverse, and complex biologically active molecules. New therapeutic approaches (e.g. targeted covalent inhibition and targeted protein degradation) provide new opportunities to address traditionally ""undruggable"" disease targets.
We anticipate that the combination of the efforts in the development of novel synthetic methodologies and therapeutic approaches will advance drug discovery in diseases of unmet need, and achieve the research goal of identifying small-molecule probes and drug candidates that specifically remove/inhibit disease-causing proteins in cells and animal models and ultimately impact human health. Representative research directions include:
1. COVID-19 drug discovery via small-molecule-induced targeted protein inhibition and degradation
2. Late-stage functionalization of drugs and peptides & its applications in drug discovery
3. Organoboron chemistry and its medical applications",Assistant Professor,Chemistry,https://scholars.library.tamu.edu/vivo/display/ncd983c6e